Table 1. Comparison of clinical characteristic among different groups (x ± s).
| Group | Age | Duration | HbA1C | FBG | SBP |
|---|---|---|---|---|---|
| (year) | (year) | (%) | (mmol/L) | (mmHg) | |
| NC | 59.7 ± 10.7 | 0 | 6.23 ± 0.70 | 5.27 ± 0.63 | 123.1 ± 19.3 |
| DM | 58.5 ± 7.70 | 5.17 ± 2.04a | 10.0 ± 2.38a | 8.51 ± 2.70a | 120.7 ± 12.2 |
| DV | 63.9 ± 7.10 | 8.25 ± 1.25ab | 9.30 ± 1.26a | 9.85 ± 5.12a | 134.6 ± 11.6ab |
| Group | DBP | TG | TC | LDL-C | HDL-C |
|---|---|---|---|---|---|
| (mmHg) | (mmol/L) | (mmol/L) | (mmol/L) | (mmol/L) | |
| NC | 79.3 ± 9.15 | 2.41 ± 1.59 | 4.91 ± 1.01 | 3.03 ± 0.63 | 1.18 ± 0.45 |
| DM | 77.7 ± 9.01 | 3.86 ± 3.79 | 5.35 ± 2.29 | 3.19 ± 1.17 | 1.01 ± 0.33 |
| DV | 75.7 ± 9.97 | 1.24 ± 0.45b | 3.06 ± 0.89ab | 1.77 ± 0.73ab | 0.98 ± 0.17 |
| Group | ALT | AST | GGT | BUN | Scr | SUA |
|---|---|---|---|---|---|---|
| (U/L) | (U/L) | (U/L) | (mmol/L) | (μmol/L) | (μmol/L) | |
| NC | 22.9 ± 8.18 | 18.8 ± 6.40 | 24.62 ± 16.9 | 4.96 ± 1.28 | 76.27 ± 37.0 | 315 ± 120 |
| DM | 22.3 ± 8.91 | 20.4 ± 8.92 | 24.4 ± 9.06 | 4.60 ± 0.90 | 71.8 ± 10.6 | 308 ± 78.0 |
| DV | 25.4 ± 12.8 | 25.9 ± 15.6 | 21.4 ± 8.37 | 6.43 ± 3.20 | 71.7 ± 13.3 | 324 ± 68.3 |
NC: Normal control group; DM: Type II diabetes mellitus without macrovascular complications; DV: Type II diabetes mellitus with macrovascular complications; HbA1C: Glycosylated hemoglobin; FPG: Fasting blood glucose; SBP: Systolic blood pressure; 1 mmHg = 0.133 kPa; DBP: Diastolic blood pressure; TG: Triglyceride; TC: Total cholesterol; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Glutamyl transpeptidase; BUN: Blood urea nitrogen; Scr: Serum creatinine; SUA: Serum uric acid. vs the NC group, aP < 0.05; vs DM, bP < 0.05.